NRPR Nutri Pharmaceuticals Research Inc (PK)

Nutri Pharmaceuticals Research, Inc. (Pink Sheets: NRPR) is pleased to report that its First Quarter 2007 Statement of Operations indicates a profit from gross revenue of approximately $500,000 in sales, an increase from 2006 of over $60,000. Nutri Pharmaceuticals Research credits their continued success to their innovative marketing strategies, introduction of their unique product to different markets and the steady growing popularity of their powders for increasing manufacturing demands. Nutri Pharmaceuticals Research is able to produce more orders for their powder products because of the company�s recent move to their new 30,000-square-foot state-of-the-art facility located in Las Vegas. �The future looks very encouraging,� says Godfrey Yew, President and CEO of Nutri Pharmaceuticals Research. �We are negotiating some exciting new projects and we believe that this will increase revenues and profitability in the near future. We are looking forward to a very successful year.� Nutri Pharmaceuticals Research has proprietary research and technology for converting oils to powders without altering the molecular structure and is beginning to produce higher revenues with significant contracts in the U.S. and abroad. Copies of the First Quarter 2007 Statement of Operations (unaudited) are available upon request. Statements in this press release other than statements of historical fact are forward-looking statements. Although management believes statements are reasonable, it can give no assurance that such expectations will be achieved.